Pharmacy Practice
Affordable Medicines
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
AUTOIMMUNE
March 15, 2019
Review of Rheumatoid Arthritis for the Pharmacist
June 15, 2018
Rheumatoid Vasculitis: A Complication of Rheumatoid Arthritis
May 31, 2018
Despite Guidelines, TNFi Therapy Appears Safe for Pregnant RA Patients
April 4, 2018
Observational Study Notes Increased IBD Risk with Common Diabetes Drug
April 4, 2018
Treating Elderly for Subclinical Hypothyroidism Can Boost Mortality Rates
March 22, 2018
Evaluating Shingles Vaccine Effectiveness in High-Risk Autoimmune Patients
February 28, 2018
Rheumatology Group’s White Paper Urges Use of Biosimilar Products When Appropriate
November 22, 2017
DMARDS Don’t Appear to Raise Risk of Second Malignancy in RA Patients Who Had Cancer
November 15, 2017
Determining Which RA Patients Are Likely to Successfully Taper Off Biologics
November 1, 2017
Awareness of Transition to Biosimilar Appears to Influence Discontinuation Rate
July 19, 2017
No Benefits for Levothyroxine in Older Subclinical Hypothyroidism Patients
June 7, 2017
Triple Therapy More Cost-Effective Than Biologics for Second-Line RA Treatment
September 28, 2016
What’s Best Next Treatment for RA Patients on Anti-TNF Biologic Agents
Load More
X
March 2019
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image